The bill establishes new regulations regarding medication abortions in Iowa, focusing on informed consent and the dispensing of abortion-inducing drugs. It defines key terms such as "abortion," "abortion-inducing drug," and "medication abortion," and mandates that facilities performing medication abortions must post a conspicuous sign informing patients about the potential ineffectiveness of medication abortions and the possibility of reversing their effects. Additionally, it requires physicians to obtain written certification from patients, confirming they have been informed of the risks associated with medication abortions and the potential for reversal, prior to the procedure.

Furthermore, the bill stipulates that the Department of Health and Human Services (HHS) must provide informational materials on its website regarding the reversal of medication abortions. It prohibits the dispensing of mifepristone outside of a healthcare setting and establishes penalties for physicians who fail to comply with these regulations. Importantly, the bill clarifies that it does not create or recognize a right to an abortion nor impose liability on women who undergo the procedure.